© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 19, 1484-1491,
October 3, 2001
© 2001 Oxford University Press
REPORT |
Complexity of Lung Cancer Modifiers: Mapping of Thirty Genes and Twenty-five Interactions in Half of the Mouse Genome
Affiliations of authors: N. Tripodis, P. Demant (Division of Molecular Genetics, H5), A. A. M. Hart (Division of Radiotherapy), The Netherlands Cancer Institute, Amsterdam; R. J. A. Fijneman, Department of Cell Biology and Immunology, Faculty of Medicine, Vrije Universiteit, Amsterdam.
Correspondence to: Peter Demant, M.D., Ph.D., Division of Molecular Genetics (H5), The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands (e-mail: demant{at}nki.nl).
Background: Numerous low-penetrance genes control susceptibility to cancer in experimental animals, but the overall genetic information on this group of genes (i.e., number of loci and their mutual interactions) is missing. We performed a systematic search, scanning roughly half of the mouse genome for lung cancer susceptibility (Sluc) genes affecting tumor size or number by using mouse recombinant congenic (RC) strains. In each RC strain (OcB), approximately 12.5% of the genome is derived from the lung cancer-resistant strain B10.O20, whereas the rest is derived from the lung cancer-susceptible strain O20. Methods: A total of 730 F2 hybrids from five (OcB x O20) crosses were tested. Pregnant mice were treated on day 18 of gestation with a single dose of N-ethyl-N-nitrosourea. When offspring were 16 weeks old, whole lungs were removed and sectioned semiserially, and the size of all lung tumors (n = 2658) was determined. Analysis of variance was used for detection of linkage, and models (including main effect and two-way interactions) were tested with a statistical program. Results: We detected a total of 30 Sluc loci (16 new plus 14 previously reported) and 25 two-way interactions. Some of these interactions are counteracting (e.g., Sluc17 and Sluc20), resulting in the partial or total masking of the individual independent effect (main effect) of each involved locus. Seven loci (Sluc1, Sluc5, Sluc12, Sluc16, Sluc18, Sluc20, and Sluc26) and two interactions (Sluc5 x Sluc12 and Sluc5 x Sluc26) were detected in more than one RC strain. Conclusions: The extrapolation of our results to the whole genome suggests approximately 60 Sluc loci (90% confidence intervals = 42 to 78). Despite the genetic complexity of lung cancer, use of appropriate mapping strategies can identify a large number of responsible loci and can reveal their interactions. This study provides an insight into the genetic control of lung tumorigenesis and may serve as a paradigm for investigating the genetics of other cancer types.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Nakai, M. S. Rogers, T. Baba, T. Funakoshi, A. E. Birsner, D. S. Luyindula, and R. J. D'Amato Genetic loci that control the size of laser-induced choroidal neovascularization FASEB J, July 1, 2009; 23(7): 2235 - 2243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Seth, J Keeley, G Abu-Ali, S Crook, D Jackson, and M Ilyas The putative tumour modifier gene ATP5A1 is not mutated in human colorectal cancer cell lines but expression levels correlate with TP53 mutations and chromosomal instability J. Clin. Pathol., July 1, 2009; 62(7): 598 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Bauer and E. A. Rondini REVIEW PAPER: The Role of Inflammation in Mouse Pulmonary Neoplasia Vet. Pathol., May 1, 2009; 46(3): 369 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vineis, S. Anttila, S. Benhamou, M. Spinola, A. Hirvonen, C. Kiyohara, S. J. Garte, R. Puntoni, A. Rannug, R. C. Strange, et al. Evidence of gene gene interactions in lung carcinogenesis in a large pooled analysis Carcinogenesis, September 1, 2007; 28(9): 1902 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tian, R. Mahmood, R. Hnasko, and J. Locker Loss of Nkx2.8 Deregulates Progenitor Cells in the Large Airways and Leads to Dysplasia Cancer Res., November 1, 2006; 66(21): 10399 - 10407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Fenske, C. McMahon, D. Edwin, J. C. Jarvis, J. M. Cheverud, M. Minn, V. Mathews, M. A. Bogue, M. A. Province, H. L. McLeod, et al. Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice. Cancer Res., May 15, 2006; 66(10): 5029 - 5038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Lee, B. Ge, C. M. T. Greenwood, D. Sinnett, Y. Fortin, S. Brunet, A. Fortin, M. Takane, E. Skamene, T. Pastinen, et al. Mapping cis-acting regulatory variation in recombinant congenic strains Physiol Genomics, April 13, 2006; 25(2): 294 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Darakhshan, C. Badie, J. Moody, M. Coster, R. Finnon, P. Finnon, A.A. Edwards, M. Szluinska, C.J. Skidmore, K. Yoshida, et al. Evidence for complex multigenic inheritance of radiation AML susceptibility in mice revealed using a surrogate phenotypic assay Carcinogenesis, February 1, 2006; 27(2): 311 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wang and M. You Five Loci, SLT1 to SLT5, Controlling the Susceptibility to Spontaneously Occurring Lung Cancer in Mice Cancer Res., September 15, 2005; 65(18): 8158 - 8165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kyoizumi, Y. Kusunoki, T. Hayashi, M. Hakoda, J. B. Cologne, and K. Nakachi Individual Variation of Somatic Gene Mutability in Relation to Cancer Susceptibility: Prospective Study on Erythrocyte Glycophorin A Gene Mutations of Atomic Bomb Survivors Cancer Res., June 15, 2005; 65(12): 5462 - 5469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Meuwissen and A. Berns Mouse models for human lung cancer Genes & Dev., March 15, 2005; 19(6): 643 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Bauer, A. M. Malkinson, and S. R. Kleeberger Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L685 - L703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. ROGERS, R. M. ROHAN, A. E. BIRSNER, and R. J. D'AMATO Genetic loci that control the angiogenic response to basic fibroblast growth factor FASEB J, July 1, 2004; 18(10): 1050 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mullerova and P. Hozak Use of Recombinant Congenic Strains in Mapping Disease-Modifying Genes Physiology, June 1, 2004; 19(3): 105 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pazzaglia, M. Mancuso, M. Tanori, M. J. Atkinson, P. Merola, S. Rebessi, V. Di Majo, V. Covelli, H. Hahn, and A. Saran Modulation of Patched-Associated Susceptibility to Radiation Induced Tumorigenesis by Genetic Background Cancer Res., June 1, 2004; 64(11): 3798 - 3806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. A. Fijneman, M. Vos, J. Berkhof, P. Demant, and G. Kraal Genetic Analysis of Macrophage Characteristics as a Tool to Identify Tumor Susceptibility Genes: Mapping of Three Macrophage-Associated Risk Inflammatory Factors, Marif1, Marif2, and Marif3 Cancer Res., May 15, 2004; 64(10): 3458 - 3464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, Z. Zhang, Y. Yan, W. J. Lemon, M. LaRegina, C. Morrison, R. Lubet, and M. You A Chemically Induced Model for Squamous Cell Carcinoma of the Lung in Mice: Histopathology and Strain Susceptibility Cancer Res., March 1, 2004; 64(5): 1647 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ewart-Toland and A. Balmain The Genetics of Cancer Susceptibility: From Mouse to Man Toxicol Pathol, January 1, 2004; 32(1_suppl): 26 - 30. [Abstract] [PDF]
|
|
|
|
|
|
M. Gariboldi, M. Spinola, S. Milani, C. Pignatiello, K. Kadota, H. Bono, Y. Hayashizaki, T. A. Dragani, and Y. Okazaki Gene expression profile of normal lungs predicts genetic predisposition to lung cancer in mice Carcinogenesis, November 1, 2003; 24(11): 1819 - 1826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nagase, J.-H. Mao, and A. Balmain Allele-specific Hras Mutations and Genetic Alterations at Tumor Susceptibility Loci in Skin Carcinomas from Interspecific Hybrid Mice Cancer Res., August 15, 2003; 63(16): 4849 - 4853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Dragani 10 Years of Mouse Cancer Modifier Loci: Human Relevance Cancer Res., June 15, 2003; 63(12): 3011 - 3018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wang, W. J. Lemon, G. Liu, Y. Wang, F. A. Iraqi, A. M. Malkinson, and M. You Fine Mapping and Identification of Candidate Pulmonary Adenoma Susceptibility 1 Genes Using Advanced Intercross Lines Cancer Res., June 15, 2003; 63(12): 3317 - 3324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Haston, M. Wang, R. E. Dejournett, X. Zhou, D. Ni, X. Gu, T. M. King, M. M. Weil, R. A. Newman, C. I. Amos, et al. Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice Hum. Mol. Genet., August 1, 2002; 11(16): 1855 - 1863. [Abstract] [Full Text] [PDF]
|
|